An opinion paper by AIIMS Delhi surgical oncologists has placed a difficult hospital-governance question at the centre of the patient-safety debate: what happens when a patient’s social influence, family connections or institutional pressure begins to shape clinical decisions? The authors argue that “VIP syndrome” can move care away from evidence-based protocols, creating avoidable risks for the influential patient while also affecting access for everyone else.
Published in Oncology Reviews, the paper by Prof. M D Ray, professor of Surgical Oncology, and his MCh student Dr Hema Siri Kottu draws on the authors’ clinical experience in oncology care. It describes how pressure from influential patients, their families or hospital management can result in unnecessary investigations, surgery before adequate preparation and prolonged intensive-care or private-ward stays.
The paper does not measure how widespread VIP culture is across hospitals. Its significance lies instead in documenting the mechanisms through which unequal treatment can enter routine clinical work. Hospitals are not only sites where doctors make decisions about diagnosis and treatment; they are also tightly managed systems in which beds, operating theatres, intensive-care capacity, nursing time and specialist attention must be allocated among competing needs.
When those decisions are altered by status rather than clinical urgency, the authors argue, the consequences can extend beyond the individual case. A patient may undergo an investigation that is not clinically necessary, a procedure may be scheduled before adequate preparation, or a hospital stay may continue longer than required. Each decision can occupy resources that are also needed by other patients.
One case described in the paper involved a 60-year-old woman with early-stage breast cancer. Her relatives insisted on a PET-CT scan, even though the authors indicate that it was not required in the circumstances described. The scan showed increased uptake in lymph nodes in the chest, leading to a further biopsy to investigate possible cancer spread. The biopsy found reactive changes rather than metastatic disease.
The case illustrates how a demand for additional certainty can produce a chain of interventions. The issue is not that patients should be prevented from asking questions or seeking second opinions. Prof. Ray said patients must remain free to do both. The concern is whether pressure from families or influential individuals can override a clinician’s assessment of what is medically appropriate.
A second case involved a 58-year-old woman with advanced ovarian cancer who underwent surgery without adequate pre-operative preparation following pressure from hospital management, according to the paper. Delayed mobilisation contributed to lung complications, and the patient remained in hospital for 12 days, compared with the usual five days for similar surgeries cited by the authors.
The reported difference is important because a hospital bed is not an isolated private asset. It is part of a wider care system. A longer stay can increase the patient’s exposure to complications, require additional staff time and delay the admission or treatment of another patient. In hospitals operating with limited capacity, clinical decisions have an operational impact even when they are made at the bedside.
The authors also describe the pressure placed on junior doctors and other staff. In one incident, a department head was asked to explain why a first-year surgical resident had removed a patient’s drain according to protocol after a relative objected to the resident performing the procedure. Such scrutiny can make staff hesitant to follow standard processes, particularly when they believe that a patient’s status or connections carry greater weight than established clinical practice.
That dynamic creates a second patient-safety problem. Protocols are designed to make care more consistent and reduce dependence on individual discretion. If staff members expect that routine actions may be challenged because of a patient’s influence, they may become more cautious about carrying out ordinary responsibilities or more willing to make exceptions. The paper’s argument is that this weakens both accountability and the culture of clinical teamwork.
The resource consequences are also visible in the authors’ observation from their oncology practice. They reported that three breast-surgery patients could have been operated on in the time occupied by one patient whose private-ward stay was extended. The authors explicitly state that this was a clinical observation and not a hospital-wide estimate. It therefore cannot establish the scale of the problem, but it does show how unequal use of time and beds can be experienced inside a department.
This distinction between observation and measurement is central to reading the paper. The authors provide case examples and professional experience rather than a prevalence study. The evidence supports a concern about how VIP treatment can affect clinical decisions and hospital resources; it does not establish how often such incidents occur across AIIMS Delhi or the wider health system.
The institutional challenge is to make fair care less dependent on informal resistance by individual doctors. The authors call for transparent admission and discharge criteria, consistent clinical protocols, better communication with patients and families, and institutional support for doctors. These measures address different points in the hospital process.
Transparent admission and discharge criteria can make decisions easier to explain and harder to alter through private pressure. Consistent protocols can provide a clinical basis for investigations, surgery and intensive-care use. Better communication can reduce the anxiety and uncertainty that often lead families to demand more tests or faster interventions. Institutional support matters because a protocol is only effective when staff can follow it without fear of reprisal.
The paper also raises a question about the meaning of equitable care in a premier hospital. Equal treatment does not mean that every patient receives exactly the same intervention. Clinical urgency, diagnosis, risk and treatment needs necessarily differ. It means that social status should not determine priority when those clinical factors do not justify a difference.
Prof. Ray said that discrimination between patients can erode trust, undermine staff morale and damage a positive work culture by allowing status and influence to take precedence over clinical need and equal dignity. His warning connects the individual case to the functioning of the institution. A hospital’s credibility depends not only on the expertise of its doctors, but also on whether patients and staff believe that its rules are applied fairly.
The paper’s central claim is therefore broader than a criticism of demanding relatives or privileged patients. It concerns the governance of scarce medical capacity. Operating theatres, beds, intensive-care units and staff attention cannot be expanded instantly in response to personal influence. When access is informally rearranged, the cost may be distributed across patients who are not present in the room and have no ability to exert similar pressure.
What the evidence establishes is limited but consequential: the AIIMS authors have documented cases in which pressure was associated with unnecessary investigation, inadequate preparation before surgery, complications, longer hospitalisation and stress for staff following protocols. What remains unestablished is the prevalence of such conduct and its impact across hospitals. That gap points to the importance of transparent institutional data and enforceable clinical processes, rather than informal hierarchies, in determining who receives care and when.
